Clinical trial
Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2
NCT00473733 · Assaf-Harofeh Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00473733 |
|---|---|
| Title | Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2 |
| Acronym | GLP |
| Lead sponsor | Assaf-Harofeh Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Procedure |
| Interventions | GLP receptors expression, ESOPHAGOGASTRODUODENOSCOPY |
| First posted | May 15, 2007 |
| Last update posted | May 15, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: